Li Chen, Qiu Yunshan, Luo Lin, Zhou Xinnan, Liu Hongli, Ouyang Ping, Geng Yi, Chen Defang, Huang Xiaoli
Department of Aquaculture, College of Animal Science & Technology, Sichuan Agricultural University, Chengdu, 611130, Sichuan, China.
Department of Basic Veterinary, College of Veterinary Medicine, Sichuan Agricultural University, Chengdu, 611130, Sichuan, China.
Fish Shellfish Immunol. 2025 Aug;163:110388. doi: 10.1016/j.fsi.2025.110388. Epub 2025 May 1.
Columnaris disease, caused by Flavobacterium columnare, has a broad host range and can afflict multiple families and genera of freshwater fish. In addition, our prior research found that Enoxolone emerged as the most promising candidate with a low minimum inhibitory concentration and good cost-effectiveness. However, the therapeutic effect of Enoxolone on Micropterus salmoides infected with F. columnare remains unclear, and its antibacterial efficiency in vivo has yet to be investigated. In this study, we found that the cumulative mortality rate of M. salmoides reached 70 % within 96 h post-infection with 1 × 10 CFU/mL F. columnare, and the gills exhibited clinical signs such as paleness and ischemia, accompanied by characteristic "Clavate Gill" pathological changes. Meanwhile, both the severity of these lesions and the bacterial load showed a significantly upward trend over time. In addition, following Enoxolone treatment, the mortality rate of M. salmoides infected by F. columnare was reduced by 40 %, with alleviated general pathological changes and a significantly lower number of apoptotic positive cells compared to the infected but untreated group. The relative expression of apoptosis and inflammation-related genes showed that the expression levels of Caspase-9, IL-18, TNF-α and NF-κB were significantly upregulated after F. columnare infection. However, the relative expression of Bcl-2 and IL-10 was significantly upregulated after treatment with Enoxolone. In conclusion, there was a positive correlation between the F. columnare load and gill damage in M. salmoides. In addition, Enoxolone has potential therapeutic and protective effects against gill tissue damage caused by F. columnare. Presumably, this efficacy may stem from the drug's ability to inhibit bacteria, thereby reducing gill cell apoptosis and inflammation. These findings provide new perspectives for future research and establish a groundwork for devising preventive and curative strategies against F. columnare infections.
柱状病由柱状黄杆菌引起,宿主范围广泛,可感染多个淡水鱼科和属。此外,我们之前的研究发现,甘草次酸是最有前景的候选药物,其最低抑菌浓度低且成本效益良好。然而,甘草次酸对感染柱状黄杆菌的大口黑鲈的治疗效果仍不清楚,其体内抗菌效率尚未得到研究。在本研究中,我们发现,用1×10CFU/mL柱状黄杆菌感染后96小时内,大口黑鲈的累积死亡率达到70%,鳃出现苍白和缺血等临床症状,并伴有特征性的“棒状鳃”病理变化。同时,这些病变的严重程度和细菌载量均随时间呈显著上升趋势。此外,经甘草次酸治疗后,感染柱状黄杆菌的大口黑鲈死亡率降低了40%,与感染但未治疗的组相比,全身病理变化减轻,凋亡阳性细胞数量显著减少。凋亡和炎症相关基因的相对表达表明,柱状黄杆菌感染后Caspase-9、IL-18、TNF-α和NF-κB的表达水平显著上调。然而,用甘草次酸治疗后,Bcl-2和IL-10的相对表达显著上调。总之,大口黑鲈体内柱状黄杆菌载量与鳃损伤之间存在正相关。此外,甘草次酸对柱状黄杆菌引起的鳃组织损伤具有潜在的治疗和保护作用。据推测,这种疗效可能源于该药物抑制细菌的能力,从而减少鳃细胞凋亡和炎症。这些发现为未来的研究提供了新的视角,并为制定针对柱状黄杆菌感染的预防和治疗策略奠定了基础。